Aspire BioPharma, Inc. (ASBP )

Currency in USD Disclaimer
$0.58 -$0.16 (-21.62%)
Open 03/14/2025
$0.53
$0.75
$0.52
$15.8

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol ASBP
  • Company Aspire BioPharma, Inc.
  • Price $0.58
  • Changes Percentage -21.62
  • Change -0.16
  • Day Low $0.53
  • Day High $0.75
  • Year High $15.8
  • Year Low $0.52
  • Market Cap $26,684,356
  • Price Avg 50 EMA (D) $8.26
  • Price Avg 200 EMA (D) $10.68
  • Exchange NASDAQ
  • Volume 14,548,676
  • Average Volume 372,213
  • Open $0.75
  • Previous Close $0.74
  • EPS -0.01
  • PE -58.00
  • Earnings Announcement 1970-01-01 00:00:00
  • Shares Outstanding $46,007,510

Company brief: ASPIRE BIOPHARMA, INC. (ASBP )

Aspire BioPharma, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

ASBP Corporation News

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

March 13, 2025 at 12:30 pm ET

accessnewswire.com -- HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug...

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

March 11, 2025 at 12:00 pm ET

newsfilecorp.com -- SmallCaps Daily Dives Deep with CEO Kraig Higginson to Discuss Aspire's Mission to Enhance Efficacy and Reduce Side Effects New York, New York--(Newsfile Corp. - March 11, 2025) - Aspire Biopharma Hol...

Income Statement